X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1400) 1400
Publication (85) 85
Book Chapter (18) 18
Book Review (9) 9
Reference (9) 9
Conference Proceeding (4) 4
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (876) 876
female (807) 807
oncology (731) 731
ovarian cancer (619) 619
index medicus (601) 601
middle aged (576) 576
aged (497) 497
obstetrics & gynecology (491) 491
survival (487) 487
ovarian neoplasms - surgery (457) 457
carcinoma (452) 452
neoadjuvant chemotherapy (441) 441
adult (423) 423
debulking surgery (420) 420
ovarian neoplasms - pathology (418) 418
surgery (415) 415
debulking (383) 383
cancer (365) 365
chemotherapy (348) 348
neoplasm staging (340) 340
retrospective studies (308) 308
cytoreductive surgery (273) 273
treatment outcome (260) 260
prognosis (253) 253
ovarian neoplasms - drug therapy (251) 251
aged, 80 and over (221) 221
ovarian neoplasms - mortality (173) 173
primary debulking surgery (169) 169
management (168) 168
neoadjuvant therapy (166) 166
interval debulking surgery (161) 161
male (151) 151
care and treatment (150) 150
chemotherapy, adjuvant (146) 146
hematology, oncology and palliative medicine (145) 145
antineoplastic combined chemotherapy protocols - therapeutic use (143) 143
survival rate (137) 137
obstetrics and gynecology (136) 136
carcinoma, ovarian epithelial (134) 134
combined modality therapy (133) 133
disease-free survival (128) 128
neoplasms, glandular and epithelial - surgery (125) 125
analysis (124) 124
survival analysis (116) 116
gynecologic-oncology-group (107) 107
neoplasms, glandular and epithelial - pathology (105) 105
primary cytoreductive surgery (105) 105
cisplatin (103) 103
ovarian neoplasms - therapy (102) 102
follow-up studies (100) 100
cytoreduction (99) 99
stage-iii (98) 98
surgical cytoreduction (97) 97
trial (96) 96
morbidity (94) 94
health aspects (92) 92
impact (91) 91
paclitaxel (90) 90
medicine & public health (87) 87
research (84) 84
cytoreduction surgical procedures (80) 80
adjuvant treatment (78) 78
laparoscopy (78) 78
advanced ovarian cancer (74) 74
peritoneal neoplasms - surgery (74) 74
disease (73) 73
residual disease (71) 71
surgical debulking (71) 71
resection (69) 69
neoplasms, glandular and epithelial - drug therapy (66) 66
ovarian carcinoma (66) 66
paclitaxel - administration & dosage (66) 66
young adult (66) 66
cytoreduction surgical procedures - methods (65) 65
tumors (65) 65
advanced-stage ovarian (64) 64
women (64) 64
antineoplastic agents - therapeutic use (62) 62
metastasis (62) 62
mortality (62) 62
patient outcomes (62) 62
fallopian-tube (61) 61
interval debulking (60) 60
cancer patients (59) 59
peritoneal neoplasms - pathology (58) 58
prognostic-factors (58) 58
carboplatin - administration & dosage (57) 57
epithelial ovarian cancer (57) 57
neoplasm recurrence, local - surgery (56) 56
metaanalysis (55) 55
ovarian neoplasms - diagnosis (55) 55
cohort studies (54) 54
complications (53) 53
epithelial ovarian (53) 53
patients (53) 53
carcinoma - surgery (51) 51
neoplasms, glandular and epithelial - mortality (51) 51
predictive value of tests (51) 51
therapy (50) 50
cyclophosphamide (49) 49
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1310) 1310
German (42) 42
French (36) 36
Korean (15) 15
Polish (7) 7
Japanese (6) 6
Italian (4) 4
Spanish (4) 4
Czech (2) 2
Russian (2) 2
Turkish (2) 2
Arabic (1) 1
Chinese (1) 1
Persian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Gynecologic Oncology, ISSN 0090-8258, 08/2018, Volume 150, Issue 2, pp. 233 - 238
To examine the relationship between volume of residual disease and oncologic outcomes among patients with advanced-stage epithelial ovarian/fallopian... 
Primary debulking surgery | Optimal debulking | Ovarian cancer
Journal Article
Acta Obstetricia et Gynecologica Scandinavica, ISSN 0001-6349, 01/2019, Volume 98, Issue 1, pp. 34 - 43
Introduction The objective of this study was to determine the impact of intra‐abdominal residual disease size, type (carcinomatosis, tumor mass or both), and... 
residual tumor | primary debulking surgery | ovarian cancer | residual disease | cytoreductive surgery | TRIALS | INTERVAL DEBULKING | TUMOR | MODEL | PREDICTION | OBSTETRICS & GYNECOLOGY | NEOADJUVANT CHEMOTHERAPY | GRADE | PROGNOSTIC-SIGNIFICANCE | SURGICAL DEBULKING
Journal Article
Monaldi Archives for Chest Disease, ISSN 1122-0643, 2019, Volume 89, Issue 2, pp. 1 - 4
Anterior mediastinal masses are relatively uncommon and include a wide variety of lesions. Lymphomas account for 25% of anterior mediastinal masses. Lymphomas... 
Mediastinum | Debulking | Lymphoma | Tamponade | debulking | tamponade | lymphoma
Journal Article
European Journal of Obstetrics & Gynecology and Reproductive Biology, ISSN 0301-2115, 06/2019, Volume 237, pp. 93 - 99
Neoadjuvant chemotherapy plus interval debulking surgery is growing treatment strategy for advanced ovarian cancer patients with unresectable disease. Here, we... 
Neoadjuvant chemotherapy | Response | RECIST | Interval debulking surgery | Ovarian cancer | DEBULKING SURGERY | PRIMARY SURGERY | REPRODUCTIVE BIOLOGY | OBSTETRICS & GYNECOLOGY
Journal Article
International Journal of Gynecological Cancer, ISSN 1048-891X, 10/2019, Volume 29, Issue 8, pp. 1327 - 1331
BackgroundPrimary cytoreductive surgery followed by chemotherapy has been considered standard management for patients with advanced ovarian cancer over... 
SURVIVAL | neoadjuvant chemotherapy | PRIMARY SURGERY | IMPACT | primary debulking surgery | ONCOLOGY | ovarian cancer | interval debulking surgery | OBSTETRICS & GYNECOLOGY
Journal Article
Hematology/Oncology Clinics of North America, ISSN 0889-8588, 02/2012, Volume 26, Issue 1, pp. 93 - 109
Journal Article
Journal of Surgical Oncology, ISSN 0022-4790, 12/2019, Volume 120, Issue 7, pp. 1208 - 1219
Background Whether patients with advanced tubo‐ovarian high‐grade serous cancer (HGSC) fare better after upfront debulking surgery (UDS) or neoadjuvant... 
ovarian high‐grade serous carcinoma | neoadjuvant chemotherapy | HIPEC | interval debulking surgery | upfront debulking surgery
Journal Article
Journal of Plastic, Reconstructive and Aesthetic Surgery, ISSN 1748-6815, 11/2014, Volume 67, Issue 11, pp. 1496 - 1501
We aimed to present blepharoplasty techniques we used for severe orbitooral neurofibromatosis (NF). A retrospective noncomparative single-center case study was... 
Orbitooral neurofibromatosis | Neurofibroma debulking | Blepharoplasty
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2016, Volume 64, pp. 22 - 31
Journal Article
Gynecologic oncology, ISSN 0090-8258, 12/2018, Volume 151, Issue 3, pp. 555 - 561
The peritoneal spread of ovarian cancer makes it a potential target for hyperthermic intraperitoneal chemotherapy (HIPEC). Intraperitoneal delivery exposes the... 
hyperthermic intraperitoneal chemotherapy | HIPEC | ovarian cancer | debulking surgery
Journal Article
Journal of Clinical and Analytical Medicine, ISSN 1309-0720, 09/2016, Volume 7, Issue 5, pp. 686 - 689
Journal Article
Journal of Clinical and Analytical Medicine, ISSN 1309-0720, 09/2016, Volume 7, Issue 5
Aim: Several factors have been described as risk factors for increased postoperative complications, such as age, performance status, surgical aggressiveness,... 
Hypoalbuminemia | debulking | complication
Journal Article
International Journal of Gynecological Cancer, ISSN 1048-891X, 11/2018, Volume 28, Issue 9, pp. 1706 - 1713
OBJECTIVEThe aim of the study was to evaluate outcomes of patients with unresectable advanced ovarian cancer experiencing complete response (CR) to neoadjuvant... 
Neoadjuvant chemotherapy | Response | Interval debulking surgery | Survival | Ovarian cancer | DEBULKING SURGERY | MANAGEMENT | OBSTETRICS & GYNECOLOGY | TRIAL | MORBIDITY | DATABASE | ONCOLOGY | PREDICTORS
Journal Article
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, ISSN 0930-2794, 04/2018, Volume 32, Issue 4, pp. 2026 - 2037
Primary cytoreduction is the mainstay of treatment for advanced ovarian cancer (AOC). We developed and prospectively evaluated an algorithm to investigate the... 
Bowel resection | DEBULKING SURGERY | SURVIVAL | SURGERY | MANAGEMENT | SURGICAL CYTOREDUCTION | FALLOPIAN-TUBE | Laparoscopy | RECURRENT OVARIAN | Primary cytoreduction | Ovarian cancer | Optimal residual tumor | HAND-ASSISTED LAPAROSCOPY | PERITONEAL CARCINOMA | Debulking | Laparoscopic surgery
Journal Article
American Journal of Surgery, ISSN 0002-9610, 04/2012, Volume 203, Issue 4, pp. 496 - 502
Background: Although resection is the only treatment option that offers a chance for prolonged survival in pancreatic cancer, R2 resections are controversial... 
Resection | Mortality | Palliative | Pancreatic cancer | Tumor debulking | Morbidity
Journal Article
International Journal of Gynecological Cancer, ISSN 1048-891X, 04/2018, Volume 28, Issue 5, pp. 945 - 950
OBJECTIVEThis study aimed to survey all practicing certified gynecological oncologists (CGOs) in Australia and New Zealand to determine their current surgical... 
Neoadjuvant chemotherapy | Optimal debulking | Cytoreductive surgery | Surgical training | Ovarian cancer | DEBULKING SURGERY | SURVIVAL | INTERVAL | METAANALYSIS | MANAGEMENT | GYNECOLOGIC-ONCOLOGY-GROUP | OBSTETRICS & GYNECOLOGY | IMPACT | ONCOLOGY | DISEASE
Journal Article
Oncotarget, ISSN 1949-2553, 2018, Volume 9, Issue 9, pp. 8614 - 8628
We aimed to performed a meta-analysis and systematic review on the role of neoadjuvant chemotherapy followed by interval debulking surgery (NACT-IDS) in... 
Neoadjuvant chemotherapy | Survival | Debulking surgery | Ovarian cancer
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.